Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 41,920 $ 11,439
Short-term investments 6,494 32,718
Prepaid expenses and other current assets 3,988 7,251
Restricted cash 0 55
Total current assets 52,402 51,463
Other assets 812 812
Deferred offering costs 70 106
Restricted cash 273 273
Property and equipment, net 405 516
Operating lease right-of-use asset (Note 8) 3,191 0
Total assets 57,153 53,170
Current liabilities:    
Accounts payable 7,177 3,653
Accrued expenses 3,801 2,103
Deferred revenue, current portion 0 121
Operating lease liability, current portion (Note 8) 36 0
Total current liabilities 11,014 5,877
Warrant liabilities 18,396 986
Loan payable expected to be refinanced (Note 7) 0 15,082
Convertible debt and derivative liability (Note 7) 11,522 0
Operating lease liability (Note 8) 3,326 0
Total liabilities 44,258 21,945
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of December 31, 2019 and December 31, 2018; 0 shares issued and outstanding as of December 31, 2019 and December 31, 2018 0 0
Common stock, $0.001 par value, 250,000,000 shares authorized as of December 31, 2019, and 125,000,000 shares authorized as of December 31, 2018; 97,413,721 and 47,971,989 shares issued and outstanding as of December 31, 2019, and December 31, 2018, respectively 97 48
Additional paid-in capital 284,226 248,895
Accumulated deficit (271,428) (217,718)
Total stockholders’ equity 12,895 31,225
Total liabilities and stockholders’ equity $ 57,153 $ 53,170